Cargando…
Clinical and electrophysiological characteristics of Efavirenz-induced macular toxicity
Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, is commonly used to treat HIV-infected individuals. We report a case of painless, progressive and bilateral blurring of vision in an HIV-positive 54-year-old lady within months of treatment with anti-retro viral therapy including Efa...
Autores principales: | Sen, Parveen, Sudharshan, Sridharan, Banerjee, Aniruddha, Dhami, Abhinav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113613/ https://www.ncbi.nlm.nih.gov/pubmed/32269906 http://dx.doi.org/10.3205/oc000135 |
Ejemplares similares
-
To evaluate the functional and anatomical outcomes for autologous retinal autograft with Finesse™ Flex Loop for failed macular holes
por: Dhami, Abhinav, et al.
Publicado: (2022) -
Clinical and visual electrophysiological characteristics of vitelliform macular dystrophies in the first decade of life
por: Padhy, Srikanta Kumar, et al.
Publicado: (2022) -
Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir
por: Patil, Rashmee, et al.
Publicado: (2015) -
Comparison of Efavirenz and Doravirine Developmental Toxicity in an Embryo Animal Model
por: Zizioli, Daniela, et al.
Publicado: (2023) -
Tuberous sclerosis complex with Best's vitelliform macular dystrophy: A combined presentation
por: Dhami, Abhinav, et al.
Publicado: (2018)